Nuwellis (NUWE) Liabilities and Shareholders Equity (2011 - 2026)
Nuwellis (NUWE) reported Liabilities and Shareholders Equity of $7.0 million for Q1 2026, down 0.64% on a YoY basis from $7.0 million in Q1 2025, and up 13.78% quarter-over-quarter from $6.1 million in Q4 2025.
Nuwellis (NUWE) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
Nuwellis has reported Liabilities and Shareholders Equity for 16 years, with the latest figure at $7.0 million in Q1 2026.
- For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 0.64% year-over-year to $7.0 million; the trailing twelve-month figure through Mar 2026 stood at $30.3 million (up 1.6% YoY), and the FY2025 full-year result was $6.1 million, down 37.98% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $7.0 million, up from $6.1 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $26.1 million in Q1 2022, with the low at $6.1 million in Q4 2025.
- Historically, Liabilities and Shareholders Equity has averaged $12.5 million across 5 years, with a median of $9.8 million in 2023.
- Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity sank 63.95% — and 2025, when it soared 48.65%.
- Nuwellis' Liabilities and Shareholders Equity stood at $24.7 million in 2022, then plunged by 60.4% to $9.8 million in 2023, then increased by 0.96% to $9.9 million in 2024, then sank by 37.98% to $6.1 million in 2025, then advanced by 13.78% to $7.0 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $7.0 million (Q1 2026), $6.1 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Nuwellis | 279,710.00 | -1.80 Mn | 1.68 Mn | 6.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.96 Mn |
| Dec 31, 2025 | 6.12 Mn |
| Sep 30, 2025 | 7.98 Mn |
| Jun 30, 2025 | 9.20 Mn |
| Mar 31, 2025 | 7.01 Mn |
| Dec 31, 2024 | 9.86 Mn |
| Sep 30, 2024 | 6.73 Mn |
| Jun 30, 2024 | 6.19 Mn |
| Mar 31, 2024 | 6.66 Mn |
| Dec 31, 2023 | 9.77 Mn |
| Sep 30, 2023 | 11.43 Mn |
| Jun 30, 2023 | 15.55 Mn |
| Mar 31, 2023 | 18.48 Mn |
| Dec 31, 2022 | 24.67 Mn |
| Sep 30, 2022 | 18.44 Mn |
| Jun 30, 2022 | 22.00 Mn |
| Mar 31, 2022 | 26.11 Mn |
| Dec 31, 2021 | 30.42 Mn |
| Sep 30, 2021 | 34.10 Mn |
| Jun 30, 2021 | 29.64 Mn |